TickerFacts.

Company research / CC

Chemours Co (CC)

Build a valuation ↗↓ Download CSV

CIK 0001627223 · NYSE · Chemicals & Allied Products

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Chemours Co reported revenue of $5.81B. Revenue grew 0.4% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $5.80B.

Key ratios (year ended 2025-12-31)

15.5%
Gross margin
-6.6%
Net margin
-153.8%
Return on year-end equity
0.4%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-01

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312025-09-302025-06-302025-03-312024-12-312023-12-312023-09-302022-12-312021-12-312020-12-31
Revenue$5.80B$5.81Bn/an/an/a$5.78B$6.08Bn/a$6.83B$6.34B$4.97B
Cost of Revenue$4.91B$4.91Bn/an/an/a$4.64B$4.78Bn/a$5.21B$4.96B$3.90B
Gross Profit$886.00M$902.00Mn/an/an/a$1.14B$1.30Bn/a$1.62B$1.38B$1.07B
R&D Expense$106.00M$108.00Mn/an/an/a$109.00M$108.00Mn/a$118.00M$107.00M$93.00M
Depreciation & Amortization$319.00M$340.00Mn/an/an/a$292.00M$309.00Mn/a$291.00M$317.00M$320.00M
Net Income-$304.00M-$386.00Mn/an/an/a$69.00M-$253.00Mn/a$578.00M$608.00M$219.00M
EPS (Diluted)n/a-$2.57n/an/an/a$0.46-$1.70n/a$3.65$3.60$1.32
Total Assets$7.15B$7.38B$7.55B$7.46B$7.38B$7.51B$8.24Bn/a$7.64B$7.55B$7.08B
Total Liabilities$7.20B$7.13Bn/a$7.23B$6.81B$6.94B$7.52B$7.20B$6.53B$6.47B$6.27B
Shareholders' Equity-$48.00M$251.00M$276.00M$230.00M$567.00M$572.00M$723.00M$749.00M$1.11B$1.08B$815.00M
Cash & Equivalents$671.00M$670.00Mn/an/an/a$713.00M$1.20Bn/a$1.10B$1.45B$1.10B
Operating Cash Flow$397.00M$264.00Mn/an/an/a-$633.00M$556.00Mn/a$755.00M$814.00M$807.00M
Capital Expenditures$179.00M$213.00Mn/an/an/a$360.00M$370.00Mn/a$307.00M$277.00M$267.00M
Free Cash Flow$218.00M$51.00Mn/an/an/a-$993.00M$186.00Mn/a$448.00M$537.00M$540.00M
Share Repurchasesn/an/an/an/an/an/a$69.00Mn/a$495.00M$173.00M$0
Dividends Paid$54.00M$78.00Mn/an/an/a$148.00M$149.00Mn/a$154.00M$164.00M$164.00M
Shares Outstanding150.46M149.89Mn/an/an/a149.43M148.59Mn/a148.50M161.05M164.92M
Dividends Per Sharen/a$0.51n/an/an/a$1.00$1.00n/a$1.00$1.00$1.00
Weighted Average Diluted Sharesn/a150.24Mn/an/an/a150.17M148.91Mn/a158.30M168.70M166.35M
EPS (Basic)n/a-$2.57n/an/an/a$0.46-$1.70n/a$3.72$3.69$1.33

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView